首页> 外文OA文献 >Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies

【2h】

Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies

机译：评估每周杜拉格拉蛋白对2型糖尿病患者患者报告的患者报告结果的影响：与黎拉纽埃德，胰岛素冰壶和安慰剂的比较两次随机研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shuichi Suzuki; Tomonori Oura; Masakazu Takeuchi; Kristina S. Boye;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies [J] . Shuichi Suzuki, Tomonori Oura, Masakazu Takeuchi, Health and Quality of Life Outcomes . 2017,第1期

机译：评估每周一次度拉鲁肽对日本2型糖尿病患者报告的结局的影响：两项随机研究与利拉鲁肽，甘精胰岛素和安慰剂的比较
2. Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study [J] . Miyagawa J., Odawara M., Takamura T., Diabetes, obesity & metabolism . 2015,第10期

机译：在日本2型糖尿病患者中，每周一次的胰高血糖素样肽1受体激动剂dulaglutide不逊于每天一次的liraglutide，并且优于安慰剂：一项为期26周的随机III期研究
3. Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study [J] . Araki E., Inagaki N., Tanizawa Y., Diabetes, obesity & metabolism . 2015,第10期

机译：在日本2型糖尿病患者中，每周一次dulaglutide联合磺脲类和/或双胍联合每日一次甘精胰岛素的疗效和安全性：一项随机，开放标签，III期非劣效性研究
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. A randomized, open-label, intervention study to evaluate the effect of diet composition on weight gain in obese, type 2 diabetes patients receiving intensive insulin therapy. [D] . Villareal, Roland. 2008

机译：一项随机，开放标签，干预性研究，以评估饮食结构对接受强化胰岛素治疗的肥胖2型糖尿病患者体重增加的影响。
6. Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide insulin glargine and placebo in two randomized studies [O] . Shuichi Suzuki, Tomonori Oura, Masakazu Takeuchi, 2017

机译：评估每周一次度拉鲁肽对日本2型糖尿病患者报告的结局的影响：两项随机研究与利拉鲁肽甘精胰岛素和安慰剂的比较
7. Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9) [O] . Paolo Pozzilli, Paul Norwood, Esteban Jódar, 2017

机译：安慰剂控制的，随机试验的加入一次每周胰高血糖素的肽-1受体激动剂杜拉蛋白达克兰蛋白酶2型糖尿病患者滴定每日胰岛素狼科（奖励-9）

Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies

著录项

引文网络

相似文献

相关主题

期刊订阅